Diabetes-Impaired Wound Healing Predicted by Urinary Nitrate Assay: A Preliminary, Retrospective Study

Wounds

Volumn 11, Issue 3, 1999, Pages 62-69

  Boykin Jr , Joseph V ^a   Kalns, John E ^b   Shawler, Lisa G ^a   Sommer, Vicki L ^a   Crossland, Mary C ^a  

^a Retreat Hospital   (United States)

^b Brook Air Force Base   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033459381     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie CC, Stern MP, et al (eds). Diabetes in America (2nd Edition). Bethesda, MD: Department of Health and Human Services, Public Health Service, National Institutes of Health, 1995:409-28 (NIH Publication No. 95-1468).
2. Beer HD, Longaker MT, Werner S. Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol 1997;109(2):132-8.
3. Steed DL. The Diabetic Ulcer Study Group. Clinical evaluation of recombinant human platelet-derived growth factor (rhPDGF-BB) for treatment of lower extremity diabetic ulcers. J Vasc Surg 1995;21:71-8.
4. Moncada S, Higgs A. The 1-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
5. Schaffer MR, Tantry U, Efron PA, et al. Diabetes-impaired healing and reduced wound nitric oxide synthesis: A possible pathophysiologic correlation. Surgery 1997;121(5):513-9.
6. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: Current status and future prospects. J Invest Dermatol 1998;110:1-7.
7. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes 1998;47:457-63.
8. Williams SB, Cusco JA, Rddy MA, Hohnston MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin dependent diabetes. J Am Coll Cardiol 1996;27(3):567-74.
9. Gilliam MB, Sherman MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 1993;212(2):359-65.
10. GraphPad Software, San Diego, California, USA, www.graphpad.com.
11. Beckman JS. The physiological and pathological chemistry of nitric oxide. In: Lancaster J (ed). Nitric Oxide. New York, NY: Academic Press, 1996:1-71.
12. Schaffer MR, Tantry U, vanWesep RA, Barbul A. Nitric oxide metabolism in wounds. J Surg Res 1997;71:25-31.
13. Papapetropoulos A, Garcia-Cardena G, Madri JA, Siss WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100(12):3131-9.
14. Noiri E, Lee E, Testa J, et al. Podokinesis in endothelial cell migration: Role of nitric oxide. Am J Physiol 1998;274(1Pt1):C236-C244.
15. Schaffer MR, Tantry U, Gross SS, Wasserburg HL, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996;63(1):237-40.
16. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovas Res 1996;32(4):743-51.
17. Shen YH, Wang XL, Wilcken DE. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett 1998;433(1-2):125-31.
18. Um SC, Suzuki S, Toyokuni S, et al. Involvement of nitric oxide in survival of random pattern skin flap. Plast Reconstr Surg 1998;101:785-92.
19. Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S. The 1-arginine: Nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biomed Biophys Res Commun 1995;209:590-5.
20. Castillo L, DeRojas RC, Chapman TE, et al. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA 1993;90:193-7.
21. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine - What does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 1998;7:59-62.
22. Bennett NT, Schultz GS. Growth factors in wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
23. Pierce GF, Mustoe TA, Lingelbach J, et al. Transforming growth factor beta reverses the glucocorticoid-induced wound healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci USA 1989;86:2229-33.
24. Vogt PM, Lehnhardt M, Wagner D, et al. Determination of endogenous growth factors in human wound fluid: Temporal presence and profiles of secretion. Plast Reconstr Surg 1998;102(1):117-23.
25. Pierce GF, Mustoe TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988;167(3):974-87.
26. Grotendorst GR, Martin GR, Pencev D, Sodek J, Harvey AK. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 1985;76:2323-9.
27. Schaffer M, Tantry U, Efron P, et al. Nitric oxide is decreased in diabetic wound healing. Langenbecks Arch Chir Suppl Kongressbd 1997;114:519-21.
28. Darby IA, Bisucci T, Hewitson TD, MacLellan DG. Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol 1997;29(1):191-200.
29. Huszka M, Kaplar M, Rejto L, et al. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thrombosis Res 1997;86(2):173-80.
30. Bulgrin JP, Shabani M, Chakravarthy D, Smith DJ. Nitric oxide synthesis is suppressed in steroid-impaired and diabetic wounds. WOUNDS 1995;7(2):48-57.
31. Maxwell AJ, Cooke JP. Cardiovascular effects of 1-arginine. Curr Opin Nephrol Hypertens 1998;7(1):63-70.
32. Martindale VE. Nitric oxide as therapeutic mechanism in HBO therapy? Presented at the 6th Annual Advanced Symposium Hyperbaric Medicine 1998 (Univ. of South Carolina), Columbia, SC, April 2, 1998.
33. Yamasaki K, Edington HDJ, McClosky C, et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998;101:967-71.
34. Bauer JA, Rao W, Smith DJ. Evaluation of linear polyethyleneimine oxide adduct on wound repair: Therapy versus toxicity. Wound Rep Reg 1998;6:569-77.